These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus. Briani C; Zara G; Rondinone R; Iaccarino L; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Sarzi-Puttini P; Doria A Autoimmunity; 2005 Nov; 38(7):549-55. PubMed ID: 16373260 [TBL] [Abstract][Full Text] [Related]
5. [The revival of thalidomide: an old drug with new indications]. Laffitte E Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497 [TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy. Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443 [TBL] [Abstract][Full Text] [Related]
7. Exacerbation of psoriasis by thalidomide in a patient with erythema multiforme. Varma K; Finlay AY Br J Dermatol; 2006 Apr; 154(4):789-90. PubMed ID: 16536837 [No Abstract] [Full Text] [Related]
8. Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma. Amato RJ; Malya R; Rawat A Am J Clin Oncol; 2008 Jun; 31(3):237-43. PubMed ID: 18525301 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide-induced neuropathy: treatment by decompression of peripheral nerves. Rose MI; Rosson GD; Elkwood AI; Dellon AL Plast Reconstr Surg; 2006 Jun; 117(7):2329-32. PubMed ID: 16772938 [No Abstract] [Full Text] [Related]
11. A case series of 48 patients treated with thalidomide. Doherty SD; Hsu S J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694 [TBL] [Abstract][Full Text] [Related]
12. Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives. Cundari S; Cavaletti G Mini Rev Med Chem; 2009 Jun; 9(7):760-8. PubMed ID: 19519501 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease. Taj A; Abbi K; Skeel RT Am J Ther; 2015; 22(1):e6-7. PubMed ID: 24105355 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide neuropathy: too much or too long? Apfel SC; Zochodne DW Neurology; 2004 Jun; 62(12):2158-9. PubMed ID: 15210874 [No Abstract] [Full Text] [Related]
15. Exacerbation of psoriasis by thalidomide in Behçet's syndrome. Dobson CM; Parslew RA Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265 [No Abstract] [Full Text] [Related]
16. Thalidomide neuropathy: role of F-wave monitoring. Rao DG; Kane NM; Oware A Muscle Nerve; 2000 Aug; 23(8):1301-2. PubMed ID: 10918274 [No Abstract] [Full Text] [Related]
17. Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone. Nijsten T; Meuleman L; Schroyens W; Lambert J Dermatology; 2002; 204(4):365-7. PubMed ID: 12077549 [TBL] [Abstract][Full Text] [Related]